Protagenic Therapeutics, Inc.\new Deferred Tax Assets, Operating Loss Carryforwards
Protagenic Therapeutics, Inc.\new (PTIX) had Deferred Tax Assets, Operating Loss Carryforwards of $21.87 million as of 2015-06-30, per its 10-K filed 2015-09-25.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2015-09-25
- 2015-06-30: Deferred Tax Assets, Operating Loss Carryforwards $21.87M.
- 2014-06-30: Deferred Tax Assets, Operating Loss Carryforwards $21.70M.
- 2013-06-30: Deferred Tax Assets, Operating Loss Carryforwards $22.43M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2015-06-30 | $21.87M 10-K · filed 2015-09-25 |
| 2014-06-30 | $21.70M 10-K · filed 2015-09-25 |
| 2013-06-30 | $22.43M 10-K · filed 2014-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |